DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 61 filers reported holding DESIGN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,402,483 | -62.5% | 6,526,476 | 0.0% | 7.89% | -55.5% |
| Q2 2023 | $41,116,799 | +9.2% | 6,526,476 | 0.0% | 17.73% | +26.4% |
| Q1 2023 | $37,657,767 | -43.8% | 6,526,476 | 0.0% | 14.03% | -42.6% |
| Q4 2022 | $66,961,644 | -28.8% | 6,526,476 | +16.0% | 24.44% | -43.2% |
| Q3 2022 | $94,075,000 | +19.4% | 5,626,476 | 0.0% | 43.01% | +11.6% |
| Q2 2022 | $78,771,000 | -13.3% | 5,626,476 | 0.0% | 38.55% | -17.1% |
| Q1 2022 | $90,868,000 | -24.6% | 5,626,476 | 0.0% | 46.52% | -31.7% |
| Q4 2021 | $120,463,000 | – | 5,626,476 | – | 68.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 5,364,850 | $78,810,000 | 3.20% |
| Logos Global Management LP | 2,772,501 | $40,728,000 | 2.94% |
| EcoR1 Capital, LLC | 1,863,098 | $27,369,000 | 0.95% |
| RA Capital Management | 2,186,636 | $32,122,000 | 0.44% |
| Vivo Capital, LLC | 530,991 | $7,800,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,468,318 | $21,570,000 | 0.34% |
| Artal Group S.A. | 400,000 | $5,876,000 | 0.13% |
| Rock Springs Capital Management LP | 334,050 | $4,907,000 | 0.10% |
| Baker Brothers Advisors | 1,436,636 | $21,104,000 | 0.09% |
| Eventide Asset Management | 400,000 | $5,876,000 | 0.08% |